Ensure healthy lives and promote well-being for all at all ages

This report provides guidance for companies to take concrete actions to integrate women's health and empowerment in their policies, systems, and operations, furthering SDGs 3, 5 and 8. The framework is based on lessons learned from consultations with companies, non-governmental organizations, and women's health programs in order to provide best practices for investing in workplace women's health and empowerment.
While most businesses understand and recognize their responsibility for the health and safety of their employees, few have connected the dots between their business actions and health outcomes in the market place, in society more generally and in the supply chain. This report outlines concrete actions for companies to embed health and empowerment in their policies, systems, and operations, advancing SDGs 3, 8 and 13.
The 2018 Lancet Countdown report directly contributes to SDG 13 (climate action), SDG 3 (good health and well-being) and SDG 9 (industry, innovation and infrastructure). The report indicates that climate change is the biggest global health threat of the 21st century. Stressing the need for governments to focus on decarbonising economies, in order to reduce rates of cardiovascular and respiratory disease, and reduce risk factors linked to infectious disease and mental illness.
RELX Group has published a new analysis, conducted by Elsevier, on SDG3: Good health and wellbeing. Looking specifically at SDG 3, this graphic provides insight into peer-reviewed research on health and three intersection with three critical health and wellbeing research areas: non-communicable disease, gender equity and climate change.
In support of SDGs 3 and 5, this Lancet Commission report presents a comprehensive agenda for global, regional, and national progress on sexual and reproductive health and rights (SRHR), up to 2030 and beyond. The report highlights why recognition of, and investment in, SRHR is pivotal to shaping future economic development and environmental sustainability, and proposes an essential package of SRHR services that should be universally available to all individuals who need them.
Elsevier,

Lancet Oncology Commission, November 2017

Lancet Oncology commission report
The report is authored by over 50 leading oncologists, including members of leading US cancer organizations, and sets out 13 key priority areas, each with measurable goals, to focus the $2 billion of funding released to the National Cancer Institute (NCI) as part of the 21st Century Cures Act. The report sets out a detailed road map to deliver on the Blue Ribbon Panel recommendations, including a focus on prevention, a new model for drug discovery and development, a vast expansion of patient access to clinical trials, and an emphasis on targeted interventions to improve cancer care for underserved groups, specifically children, cancer survivors and minority groups.
The Blueprint for Business Leadership on the SDGs aims to inspire all business — regardless of size, sector or geography — to take leading action in support of the achievement of the Sustainable Development Goals (SDGs). It illustrates how the five leadership qualities of Ambition, Collaboration, Accountability, Consistency, and Intentional can be applied to a business' strategy, business model, products, supply chain, partnerships, and operations to raise the bar and create impact at scale. The Blueprint is a tool for any business that is ready to advance its principled approach to SDG action to become a leader. This chapter relates specifically to SDG 3.
Elsevier,

Research Intelligence, August 2016

Cancer Moonshot Report
With this report, Elsevier aims to benchmark and map out the global landscape of cancer research to provide helpful new insights. Along with other materials, this benchmark report will offer the research community, pubic, policymakers and research funding organizations information on the current state of cancer related research. We hope this report will be used to inform the development of new operational approaches, priorities, policies and funding strategies to produce new knowledge that will address key challenges related to cancer in the most effective, efficient and impactful way possible.
Human health is better now than at any time in history, but these gains have come at a high price: the degradation of nature’s ecological systems on a scale never seen in human history. A growing body of evidence shows that the health of humanity is intrinsically linked to the health of the environment, but by its actions humanity now threatens to destabilise the Earth’s key life-support systems. As a Commission, we conclude that the continuing degradation of natural systems threatens to reverse the health gains seen over the last century. The SDGs provide a great opportunity to integrate health and sustainability through the judicious selection of relevant indicators relevant to human wellbeing, the enabling infrastructure for development, and the supporting natural systems, together with the need for strong governance.

Partner content

UN University

United Nations University, April 2015.

Contributing to SDGs 3 (Good health and Well-being) and 17 (Partnerships for the Goals), this concept note explores what a public health approach to global drug policy means in practice.

Pages